Pharmaceutical composition for therapy of interstitial cystitis
US7335668B2 · kind B2 · utility
1Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 8, 2002 |
| Grant date | Feb 26, 2008 |
| Priority date | — |
| Expiry date | Jan 14, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A depressant of capsaicin-sensitive sensory nerve, containing quinuclidin-3′-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate or a salt thereof as an active ingredient, specifically a therapeutic drug of interstitial cystitis, hypersensitive disorder of the lower urinary tract, and/or abacterial prostatitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.